These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17137819)

  • 1. [Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006].
    Vaylet F; Bonnichon A; Salles Y; Gontier E; Bonardel G; Lefloch H; Mairovitz A; Mantzarides M; Niang A; Marotel C; Foehrenbach H
    Cancer Radiother; 2007; 11(1-2):16-22. PubMed ID: 17137819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18Fluorodeoxyglucose positron emission tomography, a standard diagnostic tool in lung cancer.
    Giaccone G
    J Natl Cancer Inst; 2007 Dec; 99(23):1741-3. PubMed ID: 18042929
    [No Abstract]   [Full Text] [Related]  

  • 3. [Positron emission tomography in the diagnosis and follow up of non-small cell lung cancer].
    Vaylet F; Rivière F; Le Floch H; Bonnichon A; Mairovitz A; Staub E; Bonardel G; Margery J; Mantzarides M; Marotel C; Foehrenbach H
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S35-9. PubMed ID: 18235392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New horizons in staging for non-small-cell lung cancer.
    Lardinois D
    J Clin Oncol; 2006 Apr; 24(12):1785-7. PubMed ID: 16567767
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers.
    Bryant AS; Cerfolio RJ
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1363-8. PubMed ID: 17140957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
    Laking G; Price P
    Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron emission tomography imaging in nonsmall-cell lung cancer.
    Erasmus JJ; Macapinlac HA; Swisher SG
    Cancer; 2007 Nov; 110(10):2155-68. PubMed ID: 17896784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
    Liu SW; Yu JM; Xing LG
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):626-9. PubMed ID: 15634527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review.
    Mac Manus M; Hicks RJ
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1298-306. PubMed ID: 19028270
    [No Abstract]   [Full Text] [Related]  

  • 10. The standardize uptake value: light and shade of positron emission tomography.
    Bertolaccini L; Rizzardi G; Terzi A; Bianchi A
    Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):969. PubMed ID: 21659322
    [No Abstract]   [Full Text] [Related]  

  • 11. Sentinel node and positron emission tomography mapping in lung cancer.
    Nwogu C
    Semin Thorac Cardiovasc Surg; 2009; 21(4):323-6. PubMed ID: 20226345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
    Vansteenkiste JF
    Lung Cancer; 2005 Feb; 47(2):151-3. PubMed ID: 15639713
    [No Abstract]   [Full Text] [Related]  

  • 13. Author's correction. "Incidental findings on integrated PET/CT that do not accumulate 18F-FDG".
    Bruzzi JF
    AJR Am J Roentgenol; 2007 Feb; 188(2):300. PubMed ID: 17249144
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
    Strobel K; Schaefer NG; Husarik DB; Hany TF; Steinert H
    Clin Nucl Med; 2006 Oct; 31(10):624-6. PubMed ID: 16985370
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review.
    Pillot G; Siegel BA; Govindan R
    J Thorac Oncol; 2006 Feb; 1(2):152-9. PubMed ID: 17409845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan.
    Stinchcombe TE; Socinski MA; Gangarosa LM; Khandani AH
    J Clin Oncol; 2006 Oct; 24(30):4939-40. PubMed ID: 17050879
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to radiation.
    Rosenzweig KE; Fox JL; Giraud P
    Semin Radiat Oncol; 2004 Oct; 14(4):322-5. PubMed ID: 15558507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impact of 18F-fluorodeoxyglucose positron emission tomography on the 3D conformal radiotherapy planning in patients with non-small cell lung cancer].
    Bachaud JM; Marre D; Dygai I; Caselles O; Hamelin D; Bègue M; Laprie A; Zerdoud S; Gancel M; Courbon F
    Cancer Radiother; 2005 Dec; 9(8):602-9. PubMed ID: 16316759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of 18F-FDG PET in predicting outcome of cancer therapy].
    Gong HY; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):577-80. PubMed ID: 16429617
    [No Abstract]   [Full Text] [Related]  

  • 20. Positron emission tomography in lung cancer.
    Shon IH; O'doherty MJ; Maisey MN
    Semin Nucl Med; 2002 Oct; 32(4):240-71. PubMed ID: 12524650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.